News - Latest
96 news items
Olaf Dekkers sworn in as a new MEB member
Prof. O.M. (Olaf) Dekkers was sworn in as a new member of the Medicines Evaluation Board (MEB) on 23 November 2017.
MEB delighted about the EMA move to Amsterdam
The Medicines Evaluation Board (MEB) is pleased to welcome the European Medicines Agency (EMA) to Amsterdam. In its declaration ...
Launch of 3rd edition of Regulatory Science Magazine during farewell symposium for Christine Gispen-de Wied
On Wednesday 1 November 2017 a mini symposium was organised to mark the retirement of Dr Christine Gispen-de Wied, manager of the ...
National policy for labelling of medicinal products amended
The MEB has adapted the policy on labelling of medicinal products for human use. Information on this policy is contained in ...
The MEB is preparing for Brexit
The United Kingdom has decided to leave the European Union. This has consequences for the regulation of medicines in Europe. The ...
EudraVigilance Veterinary not available for 10 days starting 8 November 2017
The new EudraVigilance system for the reporting and analysis of suspected adverse reactions (ADRs) to medicinal products, will ...
Safety features protect consumers against falsified medicines
From 9 February 2019 onwards, the packaging of prescription-only medicinal products must have safety features to protect ...
EudraVigilance not available for 10 days starting 8 November 2017
The new EudraVigilance system for the reporting and analysis of suspected adverse reactions (ADRs) to medicinal products, will ...
Last call for marketing authorisation holders to submit information about in-use shelf life of OTC medicinal products
Marketing authorisation holders are obliged to include information about the in-use shelf-life of OTC medicinal products in the ...
The Dutch bid for the European Medicines Agency
Commitment, continuity, connectivity and community – those are the keywords in the Dutch bid for the EMA.